Oxford Biomedica PLC
OXB | IL
Overview
Corporate Details
- ISIN(s):
- GB00BDFBVT43
- LEI:
- 213800S1GVQNXQ15K851
- Country:
- United Kingdom
- Address:
- WINDRUSH COURT, OX4 6LT OXFORD
- Website:
- https://www.oxb.com/
- Sector:
- Professional, scientific and technical activities
- Industry:
- Research and experimental development on natural sciences and engineering
Description
Oxford Biomedica PLC is a UK-based gene and cell therapy company, providing innovative solutions for the development and manufacture of therapies.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Chat, Summarize & Extract with AI!
You have of free filing views remaining.
Upgrade for unlimited access.
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-08-01 08:00 |
Capital/Financing Update
OXB Secures New Loan Facility with Oaktree
|
English | 16.3 KB | |
| 2025-08-01 08:00 |
Declaration of Voting Results & Voting Rights Announcements
Total Voting Rights
|
English | 10.9 KB | |
| 2025-07-28 08:00 |
Earnings Release
Half Year Trading Update
|
English | 23.8 KB | |
| 2025-07-02 08:00 |
Board/Management Information
Director Declaration
|
English | 9.6 KB | |
| 2025-06-23 08:00 |
M&A Activity
OXB completes acquisition of US subsidiary
|
English | 12.3 KB | |
| 2025-06-17 19:00 |
Director's Dealing
Director/PDMR Shareholding
|
English | 18.8 KB | |
| 2025-06-11 08:02 |
Pre-Annual General Meeting Information
AGM Update
|
English | 12.6 KB | |
| 2025-06-10 11:49 |
Major Shareholding Notification
Holding(s) in Company
|
English | 22.2 KB | |
| 2025-06-05 08:00 |
Share Issue/Capital Change
Block Listing Application
|
English | 10.8 KB | |
| 2025-06-03 08:00 |
Board/Management Information
OXB Launches Advisory Board
|
English | 21.4 KB | |
| 2025-06-02 08:00 |
Declaration of Voting Results & Voting Rights Announcements
Total Voting Rights
|
English | 10.8 KB | |
| 2025-05-16 18:52 |
Director's Dealing
Grant of options
|
English | 204.1 KB | |
| 2025-04-28 14:03 |
Annual Report (ESEF)
Annual financial and audit reports
|
English | 6.4 MB | |
| 2025-04-28 14:03 |
Annual Report
Annual financial and audit reports
|
English | 17.0 MB | |
| 2025-03-27 17:45 |
Board/Management Information
Director Declaration
|
English | 10.1 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
BSF ENTERPRISE PLC | United Kingdom | BSFA | |
|
Can-Fite BioPharma Ltd. | Israel | CANF | |
|
Cantargia | Sweden | CANTA | |
|
Captor Therapeutics S.A. | Poland | CTX | |
|
Carbiotix AB | Sweden | CRBX | |
|
Cellectis | France | ALCLS | |
|
CELLULAR GOODS PLC | United Kingdom | CBX | |
|
Celyad Oncology SA | Belgium | CYAD | |
|
Cereno Scientific AB | Sweden | CRNO | |
|
Cessatech A/S | Denmark | CESSA |